Sharechat Logo

Ebos CEO Patrick Davies to step down, CFO John Cullity named as replacement

Wednesday 13th December 2017

Text too small?

Ebos Group chief executive Patrick Davies has stepped down and will be replaced by chief financial officer John Cullity from March 31 next year, the healthcare and animal products company says.

Davies will work on contract for Ebos "to assist with new and emerging opportunities," the company said. It was his decision to step down, Ebos said.

Davis became CEO in July 2014, having held the top job for six years at Symbion, the pharmaceutical wholesaler and distributor in Australia that Ebos acquired in 2013 for $1.1 billion cash and scrip, a deal which transformed the company and saw profit almost triple in 2014. Symbion’s owner Zuellig Group gained a 40 percent stake in the combined business as a result.

Cullity also joined Ebos in July 2014 after roles at Sigma Pharmaceuticals in Australia and Coca-Cola Co in the US.

Ebos shares last traded at $18.34 and have gained 9.8 percent this year.

(BusinessDesk)



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

Mercury appoints new Chief Sustainability Officer
April 24th Morning Report
VCT - Operational performance for 9 months ended 31 March 2025
April 23rd Morning Report
TWR - Capital Return - ATO Class Ruling Obtained
THL - FY25 Trading Update
April 17th Morning Report
EBOS announces opening of Retail Offer
MCY - FY2025 EBITDAF guidance revised to $760m
April 16th Morning Report